Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Start of a comparative investigator-initiated study of joint function of Episealer® patients

Episurf Medical (NASDAQ: EPIS B) today announces the start of a comparative investigator-initiated clinical study performed at the Julius Wolff Institute, Charité University Hospital, Berlin. The study with the title “X-Ray Fluoroscopic Analysis of knee joint kinematic in open and closed chain activities in patients with Episealer® Knee Implants” will follow up patients that have undergone an Episealer® procedure during the period 2015-2017 and assess the joint mobility of the treated knee and compare with healthy, non-treated knees as well as benchmark against knees that have undergone

175 Million Euro Revolving Credit Facility for Finnair

Finnair Plc           Investor news            21 January 2019 at 9:00 am EET  On 18 January 2019, Finnair Plc signed a binding EUR 175 million syndicated revolving credit facility for general corporate purposes. The coordinating bookrunner and mandated lead arranger for the facility is Nordea Bank. Danske Bank, OP Corporate Bank, Skandinaviska Enskilda Banken AB (publ) and Swedbank AB (publ) act as bookrunners and mandated lead arrangers in the facility. The loan replaces the existing EUR 175 million syndicated revolving credit facility dated 22 June 2016, which was unutilised. The

Handicare anticipates continued solid organic growth but lower than expected profit for the fourth quarter 2018

Handicare Group AB (publ) (Handicare) anticipates continued solid organic growth but lower than expected profit for the fourth quarter 2018. The lower than expected profit is primarily a result of inventory adjustments and costs related to organisational changes following the business review performed in connection with the appointment of the new CEO. Revenue is expected to increase to 73.9 MEUR (70.4) with an organic growth of 4%. Operating profit (EBIT) is estimated at 0.4 MEUR (4.4) and adjusted EBITA is estimated at 3.0 MEUR (6.2) for the fourth quarter. Revenue for the full year 2018 is

Getinge will present new innovations in medical technology at Arab Health 2019

21 January 2019Dubai Getinge, a leading global provider of innovative medical technology, announces today that it will launch the latest product innovations at Arab Health, the largest healthcare exhibition and educational platform in the Middle East & Africa.                         “We are excited to be sharing with our customers several new innovations this year at Arab Health. We will launch the Maquet PowerLED II surgical light, our Flow anesthesia portfolio and Maquet Yuno II mobile operating table” says Salah Malek, President Middle East & Africa. The Flow Anesthesia

William Hill completes offer to MRG shareholders

The Offer is not being made, and this press release may not be distributed, directly or indirectly, in or into, nor will any tender of shares be accepted from or on behalf of holders in, Australia, Canada, Hong Kong, Japan, New Zealand, South Africa or the United States or any other jurisdiction in which the making of the Offer, the distribution of this press release or the acceptance of any tender of shares would contravene applicable laws or regulations or require further offer documents, filings or other measures in addition to those required under Swedish law.  Press release  21

Interim Report Fourth Quarter 2018

Fourth quarter 2018 Continuing operations   · Order intake 25,627 million SEK · Revenues 25,968 million SEK · Operating profit 4,170 million SEK · Operating margin 16.1% · Adjusted operating profit 4,700 million SEK · Adjusted operating margin 18.1% · Profit after financial items 4,034 million SEK · Earnings per share 2.27 SEK · Cash flow from operations 6,044 million SEK Discontinued operations · Order intake -3 million SEK · Revenues 102 million SEK · Operating profit -262 million SEK Group Total · Order intake 25,624 million SEK ·

Share buy-backs in Nordic Waterproofing during week 3, 2019

During the period January 14, 2019, until and including January 18, 2019, Nordic Waterproofing Holding A/S has repurchased in total 14,617 own shares (ISIN: DK0060738409). The share buy-backs form part of the SEK 18 million share buy-back program that Nordic Waterproofing announced on December 20, 2018. The share buy-back program, which runs between December 20, 2018, and March 29, 2019, is being carried out in accordance with the Market Abuse Regulation (EU) No 596/2014 (“MAR”) and the Commission Delegated Regulation (EU) No 2016/1052 (the “Safe Harbour Regulation”).During the period

ERAS[® ]INTERACTIVE AUDIT SYSTEM FOR QUALITY IMPROVEMENT IN THE CLINICAL HEALTHCARE SETTING

A newly published article “Enhanced Recovery After Surgery Interactive Audit System: 10 years’ Experience with an international Web-Based Clinical and Research Perioperative Care Database” shows that the ERAS[®] Interactive Audit System (EIAS) supports the collaborative clinical effort in driving quality improvement in the perioperative care in a short time frame, in an international context. The safety of the established ERAS[®] Protocols has demonstrated in numerous studies the efficacy of ERAS[®]. Reduction in morbidity, faster return of bowel function, earlier mobilization,

Sandvik receives several high value-added tubular orders

Sandvik Materials Technology has received several orders for advanced tubes for the oil and gas industry at a combined value of about 1 billion SEK, with the majority being umbilical tubes. Orders were booked in the first quarter of 2019 and deliveries are scheduled as from the second half of 2019. “I am pleased that our strong product offering continue to meet customer demands, making us a key supplier of high value-added tubular products for the energy segment”, says Göran Björkman, President of Sandvik Materials Technology.   Stockholm, 21 January 2019 Sandvik AB For further

Eagle Filters receives 0,8 MEUR funding from Loudspring and enters into strategic alliance with Australian Baltec IES

Loudspring has extended an 800 000 EUR loan to its daughter company Eagle Filters. Loudspring recently agreed on 2,5M EUR growth financing from the Nordic Environmental Finance Corporation (NEFCO). The loan to Eagle Filters is the first deployment of the NEFCO funding for Loudspring, and provides Eagle Filters with the resources to accelerate its growth strategy. Loudspring owns 67,6% of Eagle Filters and has an option to increase its ownership to 80%. Eagle Filters and Australian Baltec IES  are commencing combined marketing and technology efforts to

Share buy-backs in Telia Company during week 3 2019

During the period January 14, 2019, until January 18, 2019, Telia Company AB (publ) (LEI code 213800FSR9RNDUOTXO25) has repurchased in total 2,585,000 own shares (ISIN: SE0000667925). The share buy-backs form part of the SEK 5 billion share buy-back programme that Telia Company announced on April 20, 2018. The share buy-back programme, which runs between April 23, 2018, and March 22, 2019, is being carried out in accordance with the Market Abuse Regulation (EU) No 596/2014 ("MAR") and the Commission Delegated Regulation (EU) No 2016/1052 (the "Safe Harbour Regulation").During the period

Powerbox announces power supply industry’s first Cosel portable product selector app

Powerbox , one of Europe’s largest power supply companies and a leading force for four decades in optimizing power solutions for demanding applications, has announced the release of Cosel’s first portable product selector app developed to operate across all mobile devices and computers - even without internet connection. The application has been designed for speed, and coded to offer power designers and sales forces quick access to the most important parameters, helping them to choose the best Cosel power solution for their applications in just a few clicks.

Indoor air expert: Attention must be paid to the amount of chemicals in new buildings

The impact of building materials on indoor air should be examined more.The emission class M1 for building materials is often seen as a guarantee of good indoor air. The aim of the M1 classification is to promote the development and use of low-emission products in construction. According to Juhani Pirinen, head of a business unit at FCG, the use of the classification has reduced the chemical levels in new buildings drastically. "The M1 classification ensures that the products produce fewer emissions. The classification cannot, however, enable fully emission-free construction and

Kurt Jofs to replace Staffan Bohman as Chairman of Höganäs Board of Directors

Kurt Jofs assumes the position as Chairman of the Höganäs Board on February 6, 2019. He succeeds Staffan Bohman, who has held the Chairman position for the company since 2013 when Lindéngruppen and FAM bought and delisted Höganäs from the stock exchange.“I look forward to taking over the role of Chairman and continuing Staffan Bohman’s fine work”, says Kurt Jofs. “Höganäs is an interesting company with a long and proud history, and today it has great potential in several different markets.” Kurt Jofs has been a member of the Höganäs Board of Directors since 2013. He brings with him a

BerGenBio announces start of phase I trial evaluating ADCT-601, a novel anti-AXL ADC, in patients with advanced solid tumours

· ADCT-601 uses a proprietary AXL antibody developed by BerGenBio and licensed to ADC Therapeutics for antibody drug conjugate (ADC) development · Phase I dose escalation and expansion trial will evaluate ADCT-601 in 75 cancer patients · ADCT-601 is BerGenBio’s third clinical candidate targeting AXLBergen, Norway, January 21 2019 - BerGenBio ASA (OSE:BGBIO), announces that the first patient has been dosed in a phase I clinical trial evaluating the safety, tolerability, pharmacokinetics and anti-tumour efficacy of ADCT-601, an AXL-targeting antibody drug conjugate (ADC), in patients

Targovax is invited to present at upcoming investor conferences

Oslo, Norway, 21 January 2019 - Targovax ASA (OSE: TRVX), a clinical stage biotechnology company developing immune activators to target hard-to-treat solid tumors, announces that members of its senior management team will present at upcoming investor conferences.Date: 22 January 2019Venue: Redeye Fight Cancer Seminar, Stockholm, SwedenPresenter: Erik Digman Wiklund (CBO)Presentation:-    Time: 10:45 CETPanel discussion:-    The field of Immuno-oncology - how to optimize clinical development - what trends do you see in the market?-    Time: 11:40 CETThe event can be followed

Press release English

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Sed tempus sem dapibus diam pharetra, eget eleifend enim tristique. Suspendisse potenti. Ut vitae velit eu nibh adipiscing dapibus ac eget eros. Sed faucibus gravida urna non bibendum. Donec mattis egestas ullamcorper.Donec blandit massa felis, ut laoreet mi tempus vehicula. Fusce feugiat ac mauris ac pellentesque. · Fusce vitae libero nec ligula egestas posuere. Curabitur nec commodo urna. Sed varius interdum lacus at adipiscing. · Nam sodales, turpis quis gravida ultrices, quam purus consequat leo, vel sodales nisl massa

Warm welcome for ABB Formula E in Davos

Zurich, Switzerland, January 19, 2019 Just a few days before the start of the World Economic Forum 2019, Davos is celebrating a world premiere: The latest ABB FIA Formula E racing car - dubbed Gen2 – was transported on a train from the iconic Swiss Rhaetian Railway to Europe’s highest city, where it will be an exciting eyecatcher during the coming week at the Davos Platz railway station. From this Saturday until next Sunday, January 27, the Gen2 will be on display in a special glass case. Interested passersby can learn about the ABB FIA Formula E racing series as well as about

Write-down of goodwill in Cabonline´s Year-end report 2018

The yearly impairment test in Cabonline has resulted in a non cash charge of goodwill  amounting to approximately 155 MSEK referring to the business in Finland. The Goodwill originates from the acquisition of Kovanen, Maankan Taksi and Inva-Taksi, Finland 2017.The write-down has no cash flow effect, however it has a negative impact on reported Operating income for 2018 in segment Finland. The long-term strategy regarding the presence and growth in Finland following the deregulation of the market in July 2018 remains. The amount is unaudited and the final number will be published in the Year-

WOW air hf. – All Warrant holders agree to Warrant Cancellation Agreement

ISIN: NO0010832785 – Senior Floating Rate Bonds with an aggregate outstanding amount of USD 60,000,000. Reference is made to the market announcement of WOW air (“WOW“), dated 29 November 2018, of the signing of a term sheet for the proposed investment of Indigo Partners LLC ("Indigo Partners") in WOW air. In connection with the aforementioned bonds, WOW issued on 2 November 2018 share warrant instruments (the "Warrants"). Pursuant to a Share Purchase Agreement that will be negotiated between the Indigo Investor and the shareholders of WOW, the shareholders of WOW undertook to

Decision on Extraordinary General Meeting in QuickCool AB (publ)

At a board meeting on 17 January the Board of Directors of QuickCool AB (publ) ("Quickcool" or "Company") decided to call for an extraordinary general meeting on 18 February 2019 at 17.00. (Notice will be issued in a separate press release).The Board of Directors proposes that the EGM:  Decides to change the articles of association so as to enable the aggregation of shares and decides on reducing the share capital. The board of Directors proposes that the limits of the articles of association for the share capital (§ 4) and the company's shares (§ 5) are amended in accordance with the

Decision to direct share issue to the European High Growth Opportunities Securitization Fund

The Board of Directors of QuickCool AB (publ) ("QuickCool"), supported by the authorization from the annual general meeting on May 3, 2018, decided a directed share issue, with exemption from the shareholders ' preferential rights. The new share issue has been addressed to the European High Growth opportunities Securitization Fund.The purpose of the directed share issue has been to fulfil one of the terms of the financing agreement that Quickcool entered with the European High Growth Opportunities Securitization Fund. Information about the financing agreement was provided through a press

Railcare builds generator wagons for Infranord

Railcare has received an order to build a new generation of generator wagons for the railway contracting company Infranord. The order value amounts to approximately MSEK 30 and consists of 5 wagons, designed together with Infranord. "We are excited about this collaboration with Infranord, they have the confidence in Railcare to build generator wagons that meet Infranord's high standards of adaptation for today's working environment," says Daniel Öholm, CEO Railcare Group AB. "The delivery of the wagons will begin in autumn 2019, with final delivery in 2020. The order will be reported in

There are no items matching the current filter
There are no more items matching the current filter
Back to top